Prokidney Corp. SEC filings PROK

Prokidney Corp. has 401 filings in SEC EDGAR's recent list, going back to Apr 21, 2021. Its latest annual report, Form ARS, was filed on Apr 17, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (material agreement). The company's fiscal year ends on December 31.

Prokidney Corp. SEC filings
Form Description Filed Period
8-K Current report
Material agreement
Oct 29, 2026 Oct 29, 2026
8-K Current report
Results of operations
Aug 10, 2026 Aug 10, 2026
8-K Current report
Shareholder vote results
May 29, 2026 May 28, 2026
8-K Current report
Results of operations, Regulation FD disclosure, Other events
May 15, 2026 May 15, 2026
8-K Current report
Results of operations
Mar 18, 2026 Mar 18, 2026
8-K Current report
Regulation FD disclosure, Other events
Feb 2, 2026 Feb 2, 2026
8-K Current report
Regulation FD disclosure
Jan 12, 2026 Jan 12, 2026
8-K Current report
Results of operations
Nov 10, 2025 Nov 10, 2025
8-K Current report
Material agreement
Oct 17, 2025 Oct 17, 2025
8-K Current report
Results of operations
Aug 12, 2025 Aug 12, 2025
8-K Current report
Regulation FD disclosure, Other events
Jul 15, 2025 Jul 15, 2025
8-K Current report
Material agreement, Agreement ended, Other events
Jul 14, 2025 Jul 14, 2025
8-K Current report
Regulation FD disclosure
Jul 8, 2025 Jul 8, 2025
8-K Current report
Regulation FD disclosure
Jul 1, 2025 Jul 1, 2025
8-K Current report
Shareholder vote results, Regulation FD disclosure
May 30, 2025 May 29, 2025
8-K Current report
Results of operations
May 12, 2025 May 12, 2025
8-K Current report
Results of operations
Mar 17, 2025 Mar 17, 2025
8-K Current report
Material agreement
Jan 21, 2025 Jan 17, 2025
8-K Current report
Material agreement
Nov 22, 2024 Nov 20, 2024
8-K Current report
Results of operations
Nov 12, 2024 Nov 12, 2024
8-K Current report
Regulation FD disclosure, Other events
Sep 3, 2024 Sep 3, 2024
8-K Current report
Results of operations
Aug 9, 2024 Aug 9, 2024
8-K Current report
Material agreement, Other events
Jun 13, 2024 Jun 11, 2024
8-K Current report
Regulation FD disclosure, Other events
Jun 10, 2024 Jun 10, 2024
8-K Current report
Shareholder vote results
May 31, 2024 May 30, 2024
8-K Current report
Regulation FD disclosure
May 29, 2024 May 29, 2024
8-K Current report
Results of operations
May 10, 2024 May 10, 2024
8-K Current report
Officer or director change, Regulation FD disclosure
Mar 25, 2024 Mar 25, 2024
8-K Current report
Results of operations
Mar 22, 2024 Mar 21, 2024
8-K/A Amended current report
Officer or director change
Mar 18, 2024 Nov 28, 2023
8-K/A Amended current report
Officer or director change
Mar 18, 2024 Nov 10, 2023
8-K Current report
Officer or director change
Feb 12, 2024 Feb 6, 2024
8-K Current report
Regulation FD disclosure
Jan 26, 2024 Jan 25, 2024
8-K Current report
Material agreement
Jan 19, 2024 Jan 19, 2024
8-K/A Amended current report
Officer or director change
Dec 5, 2023 Nov 10, 2023
8-K Current report
Officer or director change
Nov 30, 2023 Nov 28, 2023
8-K Current report
Regulation FD disclosure
Nov 20, 2023 Nov 19, 2023
8-K Current report
Results of operations
Nov 14, 2023 Nov 14, 2023
8-K Current report
Officer or director change, Regulation FD disclosure, Other events
Nov 13, 2023 Nov 10, 2023
8-K Current report
Regulation FD disclosure
Sep 11, 2023 Sep 11, 2023
8-K Current report
Results of operations
Aug 10, 2023 Aug 10, 2023
8-K Current report
Other events
Jul 18, 2023 Jul 17, 2023
8-K Current report
Shareholder vote results
Jun 30, 2023 Jun 29, 2023
8-K Current report
Material agreement
Jun 16, 2023 Jun 13, 2023
8-K Current report
Results of operations
May 11, 2023 May 11, 2023
8-K Current report
Results of operations
Mar 28, 2023 Mar 28, 2023
8-K Current report
Other events
Mar 6, 2023 Mar 6, 2023
8-K Current report
Other events
Feb 6, 2023 Feb 3, 2023
8-K Current report
Officer or director change
Jan 19, 2023 Jan 17, 2023
8-K Current report
Other events
Jan 10, 2023 Jan 10, 2023
8-K Current report
Regulation FD disclosure
Jan 10, 2023 Jan 10, 2023
8-K Current report
Officer or director change
Dec 6, 2022 Dec 2, 2022
8-K Current report
Results of operations
Nov 14, 2022 Nov 14, 2022
8-K Current report
Regulation FD disclosure
Sep 8, 2022 Sep 8, 2022
8-K/A Amended current report
Acquisition or sale of assets
Aug 12, 2022 Jul 11, 2022
8-K Current report
Results of operations
Aug 12, 2022 Aug 11, 2022
8-K Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Auditor change, Change in control, Officer or director change, Bylaw or fiscal year change, Other events
Jul 15, 2022 Jul 11, 2022
8-K Current report
Listing notice, Officer or director change, Shareholder vote results, Regulation FD disclosure, Other events
Jul 12, 2022 Jul 8, 2022
8-K Current report
Shareholder vote results, Other events
Jul 11, 2022 Jul 6, 2022
8-K Current report
Other events
Jul 6, 2022 Jul 6, 2022
8-K/A Amended current report
Other events
Jun 10, 2022 Jul 2, 2021
8-K Current report
Regulation FD disclosure
Apr 28, 2022 Apr 28, 2022
8-K Current report
Material agreement, New debt
Apr 22, 2022 Apr 20, 2022
8-K/A Amended current report
Material agreement, Unregistered share sale
Jan 21, 2022 Jan 18, 2022
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Jan 18, 2022 Jan 18, 2022
8-K Current report
Restatement
Nov 16, 2021 Nov 15, 2021
8-K Current report
Officer or director change
Sep 24, 2021 Sep 24, 2021
8-K Current report
Other events
Jul 9, 2021 Jul 2, 2021
8-K Current report
Material agreement, Unregistered share sale, Officer or director change, Bylaw or fiscal year change, Other events
Jul 2, 2021 Jun 29, 2021

Showing 69 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
PROK (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Cayman Islands
Headquarters
Winston-Salem, NC
SEC filer status
, Emerging growth company
SEC CIK
1850270
Former names
Social Capital Suvretta Holdings Corp. III (until Jul 11, 2022)

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.